{"id":84814,"date":"2026-05-20T12:31:55","date_gmt":"2026-05-20T12:31:55","guid":{"rendered":"https:\/\/www.cofb.org\/?p=84814"},"modified":"2026-05-22T12:33:00","modified_gmt":"2026-05-22T12:33:00","slug":"claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/","title":{"rendered":"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB"},"content":{"rendered":"\n

El passat 12 de maig, el Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> va organitzar, amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/a>, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d<\/strong>, amb el patrocini de Johnson & Johnson<\/a>. La jornada va ser impartida per Ernest Nadal<\/strong>, onc\u00f2leg, cap de secci\u00f3 de Tumors Tor\u00e0cics, Cerebrals i de Cap i Coll i onc\u00f2leg m\u00e8dic especialitzat en c\u00e0ncer de pulm\u00f3 de l\u2019Institut Catal\u00e0 d\u2019Oncologia (ICO) i director de Recerca i Innovaci\u00f3 Corporatiu de l\u2019ICO; Francesc Alamon<\/strong>, dermat\u00f2leg adjunt a l’Hospital Cl\u00ednic de Barcelona, membre de l’equip de Toxoncologia i del Comit\u00e8 de Farmacovigil\u00e0ncia, membre de la Task Force “Dermatology for Cancer Patients” de la European Academy of Dermatology and Venereology; Jes\u00fas P\u00e9rez<\/strong>, corresponsable del Departament d\u2019Oncologia de La Roche Posay, i col\u00b7laborador extern de l\u2019Escola Universit\u00e0ria d\u2019Infermeria de l\u2019Hospital de la Santa Creu i Sant Pau de Barcelona (UAB); i Gemma Puig<\/strong>, farmac\u00e8utica especialista en farm\u00e0cia hospital\u00e0ria, secret\u00e0ria de la Comissi\u00f3 Assessora de Medicaci\u00f3 Hospital\u00e0ria (CAMH) del CatSalut i coordinadora de les Pautes d\u2019harmonitzaci\u00f3 del tractament farmacol\u00f2gic del c\u00e0ncer de pulm\u00f3 no microc\u00edtic al SISCAT. La sessi\u00f3, adre\u00e7ada a farmac\u00e8utics i farmac\u00e8utiques d\u2019hospital i d\u2019atenci\u00f3 prim\u00e0ria<\/strong>, va ser coordinada pel vocal d\u2019Hospitals del COFB, David Conde<\/strong>.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Els objectius <\/strong>de la formaci\u00f3 van ser revisar la fisiopatologia i les dianes terap\u00e8utiques del c\u00e0ncer de pulm\u00f3<\/strong>, actualitzar els darrers tractaments aprovats pel c\u00e0ncer de pulm\u00f3<\/strong>, con\u00e8ixer les afectacions dermatol\u00f2giques derivades dels tractaments<\/strong> i reflexionar sobre els mecanismes per a la incorporaci\u00f3 de la innovaci\u00f3 <\/strong>en el sistema sanitari.<\/p>\n\n\n\n

Novetats en el tractament del c\u00e0ncer de pulm\u00f3<\/strong><\/h2>\n\n\n\n

La primera part de la jornada va anar c\u00e0rrec del doctor Ernest Nadal<\/strong> que va exposar quines novetats hi ha en el tractament del c\u00e0ncer de pulm\u00f3<\/strong>, \u201cuna malaltia amb un gran impacte de salut p\u00fablica en el m\u00f3n, ja que, a escala mundial, \u00e9s la primera causa de mort\u201d.<\/strong> Segons va indicar, ens els registres de c\u00e0ncer espanyols es pot observar com, \u201cen el cas dels homes, hi ha hagut una disminuci\u00f3 en el diagn\u00f2stic per c\u00e0ncer de pulm\u00f3 per\u00f2, en el cas de les dones, hi ha un augment preocupant en les dones\u201d. Tanmateix, va destacar que hi ha una certa desigualtat relacionada amb els determinants socials en relaci\u00f3 amb la mortalitat per c\u00e0ncer de pulm\u00f3.<\/strong><\/p>\n\n\n\n

\"\"<\/a>
L’onc\u00f2leg en un moment de la seva exposici\u00f3. <\/figcaption><\/figure>\n\n\n\n

El Dr. Nadal va mostrar l\u2019evoluci\u00f3 de la quimioter\u00e0pia<\/strong> com a tractament del c\u00e0ncer de pulm\u00f3 amb els anys, aix\u00ed com l\u2019arribada de la medicina de precisi\u00f3<\/strong> que ha tingut un gran impacte en la reducci\u00f3 de la mortalitat<\/strong>. El doctor va assegurar que \u201cla identificaci\u00f3 d\u2019alteracions driver<\/em> tractables i l\u2019acc\u00e9s a la seq\u00fcenciaci\u00f3 massiva (NGS) s\u00f3n clau en el pla de tractament dels pacients amb c\u00e0ncer de pulm\u00f3 no microc\u00edtic (CPNM) i determinen decisions terap\u00e8utiques i efici\u00e8ncia del sistema\u201d. No obstant aix\u00f2, va dir que existeix una gran inequitat en l’acc\u00e9s a la NGS a escala mundial i aix\u00f2 pot comprometre les opcions de tractament, per\u00f2 \u201ca Catalunya la Instrucci\u00f3 i el Programa de Medicina de Precisi\u00f3 del CatSalut han apostat per l’equitat i l’accessibilitat\u201d. Al llarg de la seva exposici\u00f3, Nadal va aprofundir en l\u2019arsenal terap\u00e8utic disponible per al c\u00e0ncer de pulm\u00f3.<\/p>\n\n\n\n

Efectes dermatol\u00f2gics derivats del tractament del c\u00e0ncer de pulm\u00f3<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3, va intervenir el dermat\u00f2leg, Francesc Alamon<\/strong>, per abordar els efectes dermatol\u00f2gics m\u00e9s comuns derivats del tractament per al c\u00e0ncer de pulm\u00f3<\/strong>. El doctor va mostrar, a trav\u00e9s de diversos casos cl\u00ednics cutanis, els diferents aspectes de gravetat: pacients que tindran s\u00edmptomes cutanis que seran merament est\u00e8tics; fins a pacients que presentaran quadres greus, que poden arribar a comportar la suspensi\u00f3 de la ter\u00e0pia per la seva neopl\u00e0sia. \u201cMolts d’aquests casos, els que presentin s\u00edmptomes m\u00e9s lleus<\/strong>, els podrem manejar amb tractament<\/strong> simptom\u00e0tic o t\u00f2pic<\/strong>, mentre d\u2019altres en requeriran un de sist\u00e8mic<\/strong> i parlar de forma multidisciplin\u00e0ria amb els onc\u00f2legs per valorar cada cas\u201d, va argumentar.<\/p>\n\n\n\n

\"\"<\/a>
El dermat\u00f2leg durant la seva presentaci\u00f3 sobre els efectes dermatol\u00f2gics derivats del tractament del c\u00e0ncer de pulm\u00f3.<\/figcaption><\/figure>\n\n\n\n

Alamon va repassar les diferents mesures generals<\/strong> a seguir amb tots els pacients de forma proactiva, les principals toxicitats cut\u00e0nies<\/strong> segons el tractament pautat i els criteris d\u2019alarma o derivaci\u00f3<\/strong>. \u201cEl tractament s’ha d’adaptar al grau de toxicitat: cures b\u00e0siques des de l’inici, antibi\u00f2tics t\u00f2pics en fases primerenques i tetraciclines orals (doxiciclina\/minociclina) en toxicitat de grau \u22652<\/strong>\u201d, va apuntar. El Dr. Alamon va concloure la seva exposici\u00f3 assegurant que \u201cla prioritat \u00e9s mantenir el tractament antineopl\u00e0stic mitjan\u00e7ant el maneig preventiu, preco\u00e7 i proactiu (les tres P) de les reaccions adverses cut\u00e0nies<\/strong>\u201d.<\/p>\n\n\n\n

Tractament dermocosm\u00e8tic coadjuvant en el tractament de la pell<\/strong><\/h3>\n\n\n\n

Per la seva banda, el responsable nacional del Departament d\u2019oncologia de La Roche-Posay, Jes\u00fas P\u00e9rez<\/strong>, va incidir en el tractament dermocosm\u00e8tic coadjuvant. A l\u2019inici de la seva exposici\u00f3 P\u00e9rez va compartir algunes dades generals, en relaci\u00f3 amb els efectes dels tractaments per al c\u00e0ncer: el 96% dels pacients pateixen efectes adversos en la pell a causa dels tractaments<\/strong>; el<\/strong> 74% han hagut d\u2019interrompre<\/strong> i incl\u00fas abandonar<\/strong> els tractaments oncol\u00f2gics deguts als efectes adversos en la pell; el 80% asseguren que la cura de la pell i el suport psicol\u00f2gic els ha ajudat a afrontar millor la malaltia<\/strong>; i el 84% dels pacients mai han estat derivats a una interconsulta amb el servei de dermatologia<\/strong>. Tanmateix, va descriure els efectes adversos m\u00e9s freq\u00fcents <\/strong>com \u00e9s la xerosi, queratosis pilar, prurit, erupci\u00f3 acne\u00efforme, exantema, alteracions a les ungles, reacci\u00f3 cut\u00e0nia m\u00e0-peu, radiodermitis i fotosensibilitat.<\/p>\n\n\n\n

\"\"<\/a>
Jes\u00fas P\u00e9rez en un moment de la seva intervenci\u00f3. <\/figcaption><\/figure>\n\n\n\n

\u201cLa pell i els seus annexos s’alteren a conseq\u00fc\u00e8ncia dels tractaments oncol\u00f2gics, afectant a nivell f\u00edsic, funcional i psicol\u00f2gic, disminuint profundament la qualitat de vida\u201d<\/strong>, va indicar. Per tancar la seva exposici\u00f3, va recordar que les cures dermocosm\u00e8tiques recomanades reforcen la barrera cut\u00e0nia i la seva home\u00f2stasi, redueixen l\u2019impacte de la toxicitat cut\u00e0nia, disminueixen o prevenen els efectes secundaris, augmenten la qualitat de vida i milloren l\u2019adher\u00e8ncia a les ter\u00e0pies farmacol\u00f2giques i\/o f\u00edsiques.  <\/p>\n\n\n\n

Qualitat de vida i perspectives de futur per la persona amb c\u00e0ncer de pulm\u00f3<\/strong><\/h2>\n\n\n\n

En darrer lloc, la farmac\u00e8utica especialista en farm\u00e0cia hospital\u00e0ria, Gemma Puig, <\/strong>es va centrar en l\u2019abordatge de la qualitat de vida i les perspectives de futur per a les persones amb c\u00e0ncer de pulm\u00f3. \u201cLa qualitat de vida \u00e9s una avaluaci\u00f3 multidimensional de l\u2019experi\u00e8ncia del pacient en relaci\u00f3 amb la seva malaltia i tractament\u201d, la qual cosa \u201cpermet una valoraci\u00f3 directa per al mateix pacient\u201d, va comentar. Pel que fa als nous tractaments (immunoter\u00e0pia i ter\u00e0pia dirigida), \u201ces relacionen <\/strong>amb una millor qualitat de vida global. Tanmateix, el seu perfil de toxicitat pot tenir un impacte diferent en la qualitat de vida\u201d, va concretar.<\/p>\n\n\n\n

\"\"<\/a>
Gemma Puig durant la seva presentaci\u00f3 sobre qualitat de vida i perspectives de futur per la persona amb c\u00e0ncer de pulm\u00f3.<\/figcaption><\/figure>\n\n\n\n

La farmac\u00e8utica va repassar els factors que poden afectar la qualitat de vida, les limitacions en la mesura, l\u2019afectaci\u00f3 deguda al tractament, els efectes dermatol\u00f2gics dels nous tractaments i qualitat de vida i les limitacions en la mesura de l\u2019efecte de la toxicitat dermatol\u00f2gica en la qualitat de vida. \u201c\u00c9s necessari incorporar a la pr\u00e0ctica cl\u00ednica l\u2019efecte de la toxicitat dermatol\u00f2gica en la qualitat de vida. Tanmateix, cal seleccionar de forma adequada l\u2019escala o escales que permetin recollir tota l\u2019afectaci\u00f3 i que alhora siguin aplicables en el dia a dia\u201d<\/strong>, va dir Puig per tancar la formaci\u00f3.<\/p>\n\n\n\n

\n
\n
\n
<\/div>\n\n\n\n
\n

Amb la col\u00b7laboraci\u00f3 de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

El passat 12 de maig, el Col\u00b7legi de Farmac\u00e8utics de Barcelona va organitzar, amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d, amb el patrocini de Johnson & Johnson. La jornada va ser impartida per […]<\/p>\n","protected":false},"author":3,"featured_media":84818,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[938,723,979,18,19,5541,2881,2729,53,2965,70,5539,5542,2606,5538,63,5540],"class_list":["post-84814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-primaria","tag-cancer","tag-cancer-de-pulmo","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-efectes-dermatologics","tag-farmaceutic-atencio-primaria","tag-farmaceutic-dhospital","tag-farmaceutics","tag-farmaceutics-dhospitals","tag-formacio","tag-maneig-dermatologic","tag-medicina","tag-medicina-de-precisio","tag-pulmo","tag-tractament","tag-tractament-dermatologic"],"yoast_head":"\nClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 12 de maig, el COFB va organitzar, amb la col\u00b7laboraci\u00f3 de laSCFC, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 12 de maig, el COFB va organitzar, amb la col\u00b7laboraci\u00f3 de laSCFC, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-20T12:31:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-22T12:33:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB\",\"datePublished\":\"2026-05-20T12:31:55+00:00\",\"dateModified\":\"2026-05-22T12:33:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\"},\"wordCount\":1430,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"c\u00e0ncer\",\"c\u00e0ncer de pulm\u00f3\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"efectes dermatol\u00f2gics\",\"farmac\u00e8utic atenci\u00f3 prim\u00e0ria\",\"farmac\u00e8utic d'hospital\",\"farmac\u00e8utics\",\"farmac\u00e8utics d'hospitals\",\"Formaci\u00f3\",\"maneig dermatol\u00f2gic\",\"medicina\",\"medicina de precisi\u00f3\",\"pulm\u00f3\",\"tractament\",\"tractament dermatol\u00f2gic\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\",\"url\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\",\"name\":\"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg\",\"datePublished\":\"2026-05-20T12:31:55+00:00\",\"dateModified\":\"2026-05-22T12:33:00+00:00\",\"description\":\"El passat 12 de maig, el COFB va organitzar, amb la col\u00b7laboraci\u00f3 de laSCFC, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 12 de maig, el COFB va organitzar, amb la col\u00b7laboraci\u00f3 de laSCFC, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/","og_locale":"ca_ES","og_type":"article","og_title":"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 12 de maig, el COFB va organitzar, amb la col\u00b7laboraci\u00f3 de laSCFC, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d","og_url":"https:\/\/www.cofb.org\/ca\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2026-05-20T12:31:55+00:00","article_modified_time":"2026-05-22T12:33:00+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Berta Mart\u00ednez","Temps estimat de lectura":"9 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB","datePublished":"2026-05-20T12:31:55+00:00","dateModified":"2026-05-22T12:33:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/"},"wordCount":1430,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg","keywords":["Atenci\u00f3 prim\u00e0ria","c\u00e0ncer","c\u00e0ncer de pulm\u00f3","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","efectes dermatol\u00f2gics","farmac\u00e8utic atenci\u00f3 prim\u00e0ria","farmac\u00e8utic d'hospital","farmac\u00e8utics","farmac\u00e8utics d'hospitals","Formaci\u00f3","maneig dermatol\u00f2gic","medicina","medicina de precisi\u00f3","pulm\u00f3","tractament","tractament dermatol\u00f2gic"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/","url":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/","name":"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg","datePublished":"2026-05-20T12:31:55+00:00","dateModified":"2026-05-22T12:33:00+00:00","description":"El passat 12 de maig, el COFB va organitzar, amb la col\u00b7laboraci\u00f3 de laSCFC, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2026\/05\/20\/claus-en-el-tractament-i-el-maneig-dermatologic-del-cancer-de-pulmo-nova-formacio-al-cofb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Claus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3. Nova formaci\u00f3 al COFB"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_CANCER-PULMO_22052026_0-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 12 de maig, el Col\u00b7legi de Farmac\u00e8utics de Barcelona va organitzar, amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica, la formaci\u00f3 \u201cClaus en el tractament i el maneig dermatol\u00f2gic del c\u00e0ncer de pulm\u00f3\u201d, amb el patrocini de Johnson & Johnson. La jornada va ser impartida per […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/84814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=84814"}],"version-history":[{"count":6,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/84814\/revisions"}],"predecessor-version":[{"id":84826,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/84814\/revisions\/84826"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/84818"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=84814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=84814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=84814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}